PI3K/AKT/mTOR Signaling Pathway Is Required for JCPyV Infection in Primary Astrocytes

被引:8
|
作者
Wilczek, Michael P. [1 ]
Armstrong, Francesca J. [1 ]
Mayberry, Colleen L. [1 ]
King, Benjamin L. [1 ,2 ]
Maginnis, Melissa S. [1 ,2 ]
机构
[1] Univ Maine, Dept Mol & Biomed Sci, Orono, ME 04469 USA
[2] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA
基金
美国国家卫生研究院;
关键词
JC polyomavirus; PML; astrocytes; SVGA cells; primary cells; PI3K; AKT; mTOR; rapamycin; wortmannin; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; LARGE T-ANTIGEN; JC VIRUS-DNA; MATRIX-METALLOPROTEINASE EXPRESSION; MULTIPLE-SCLEROSIS; BK POLYOMAVIRUS; GENE-EXPRESSION; CELL BIOLOGY; GLIAL-CELLS; PROTEIN;
D O I
10.3390/cells10113218
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Astrocytes are a main target of JC polyomavirus (JCPyV) in the central nervous system (CNS), where the destruction of these cells, along with oligodendrocytes, leads to the fatal disease progressive multifocal leukoencephalopathy (PML). There is no cure currently available for PML, so it is essential to discover antivirals for this aggressive disease. Additionally, the lack of a tractable in vivo models for studying JCPyV infection makes primary cells an accurate alternative for elucidating mechanisms of viral infection in the CNS. This research to better understand the signaling pathways activated in response to JCPyV infection reveals and establishes the importance of the PI3K/AKT/mTOR signaling pathway in JCPyV infection in primary human astrocytes compared to transformed cell lines. Using RNA sequencing and chemical inhibitors to target PI3K, AKT, and mTOR, we have demonstrated the importance of this signaling pathway in JCPyV infection of primary astrocytes not observed in transformed cells. Collectively, these findings illuminate the potential for repurposing drugs that are involved with inhibition of the PI3K/AKT/mTOR signaling pathway and cancer treatment as potential therapeutics for PML, caused by this neuroinvasive virus.
引用
收藏
页数:25
相关论文
共 50 条
  • [41] Rapamycin reduces podocyte damage by inhibiting the PI3K/AKT/mTOR signaling pathway and promoting autophagy
    Yu, Shengyou
    Ren, Qi
    Chen, Jing
    Huang, Jing
    Liang, Rui
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [42] The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances
    Khorasani, Ayda Baghery Saghchy
    Hafezi, Nasim
    Sanaei, Mohammad-Javad
    Jafari-Raddani, Farideh
    Pourbagheri-Sigaroodi, Atieh
    Bashash, Davood
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (03)
  • [43] Rapamycin reduces podocyte damage by inhibiting the PI3K/AKT/mTOR signaling pathway and promoting autophagy
    Yu, Shengyou
    Ren, Qi
    Chen, Jing
    Huang, Jing
    Liang, Rui
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [44] CAMK1D Inhibits Glioma Through the PI3K/AKT/mTOR Signaling Pathway
    Jin, Qianxu
    Zhao, Jiahui
    Zhao, Zijun
    Zhang, Shiyang
    Sun, Zhimin
    Shi, Yunpeng
    Yan, Hongshan
    Wang, Yizheng
    Liu, Liping
    Zhao, Zongmao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] GRP94 promotes muscle differentiation by inhibiting the PI3K/AKT/mTOR signaling pathway
    Li, Shuang
    Fu, Yuying
    Pang, Yusheng
    Tong, Huili
    Li, Shufeng
    Yan, Yunqin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 21211 - 21223
  • [46] Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration
    Fakhri, Sajad
    Iranpanah, Amin
    Gravandi, Mohammad Mehdi
    Moradi, Seyed Zachariah
    Ranjbari, Mohammad
    Majnooni, Mohammad Bagher
    Echeverria, Javier
    Qi, Yaping
    Wang, Mingfu
    Liao, Pan
    Farzaei, Mohammad Hosein
    Xiao, Jianbo
    PHYTOMEDICINE, 2021, 91
  • [47] Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding
    Sami, Arshawn
    Karsy, Michael
    TUMOR BIOLOGY, 2013, 34 (04) : 1991 - 2002
  • [48] Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway
    Kumar, Dhruv
    Shankar, Sharmila
    Srivastava, Rakesh K.
    CANCER LETTERS, 2014, 343 (02) : 179 - 189
  • [49] Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway
    Du, Liyan
    Li, Xiaomei
    Zhen, Linhong
    Chen, Weiling
    Mu, Lingguang
    Zhang, Yang
    Song, Ailin
    MOLECULAR MEDICINE REPORTS, 2018, 17 (05) : 7163 - 7169
  • [50] Resveratrol attenuates intestinal injury in irradiated rats via PI3K/Akt/mTOR signaling pathway
    Radwan, Rasha R.
    Karam, Heba M.
    ENVIRONMENTAL TOXICOLOGY, 2020, 35 (02) : 223 - 230